A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease

Abstract Dyspnoea is a cardinal symptom of fibrotic interstitial lung disease (ILD), with a lack of proven effective therapies. With emerging evidence of the role of facial and nasal airflow for relieving breathlessness, this pilot study was conducted to examine the feasibility of conducting a clini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yet H. Khor, Kirushallini Saravanan, Anne E. Holland, Joanna Y. T. Lee, Christopher J. Ryerson, Christine F. McDonald, Nicole S. L. Goh
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cb52a0d140ab45edb402fb7a2ff021ce
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cb52a0d140ab45edb402fb7a2ff021ce
record_format dspace
spelling oai:doaj.org-article:cb52a0d140ab45edb402fb7a2ff021ce2021-12-02T16:36:12ZA mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease10.1038/s41598-021-86326-82045-2322https://doaj.org/article/cb52a0d140ab45edb402fb7a2ff021ce2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-86326-8https://doaj.org/toc/2045-2322Abstract Dyspnoea is a cardinal symptom of fibrotic interstitial lung disease (ILD), with a lack of proven effective therapies. With emerging evidence of the role of facial and nasal airflow for relieving breathlessness, this pilot study was conducted to examine the feasibility of conducting a clinical trial of a handheld fan (HHF) for dyspnoea management in patients with fibrotic ILD. In this mixed-methods, randomised, assessor-blinded, controlled trial, 30 participants with fibrotic ILD who were dyspnoeic with a modified Medical Research Council Dyspnoea grade ≥ 2 were randomised to a HHF for symptom control or no intervention for 2 weeks. Primary outcomes were trial feasibility, change in Dyspnoea-12 scores at Week 2, and participants’ perspectives on using a HHF for dyspnoea management. Study recruitment was completed within nine months at a single site. Successful assessor blinding was achieved in the fan group [Bang’s Blinding Index − 0.08 (95% CI − 0.45, 0.30)] but not the control group [0.47 (0.12, 0.81)]. There were no significant between-group differences for the change in Dyspnoea-12 or secondary efficacy outcomes. During qualitative interviews, participants reported that using the HHF relieved breathlessness and provided relaxation, despite initial scepticism about its therapeutic benefit. Oxygen-experienced participants described the HHF being easier to use, but not as effective for symptomatic relief, compared to oxygen therapy. Our results confirmed the feasibility of a clinical trial of a HHF in fibrotic ILD. There was a high level of patient acceptance of a HHF for managing dyspnoea, with patients reporting both symptomatic benefits and ease of use.Yet H. KhorKirushallini SaravananAnne E. HollandJoanna Y. T. LeeChristopher J. RyersonChristine F. McDonaldNicole S. L. GohNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yet H. Khor
Kirushallini Saravanan
Anne E. Holland
Joanna Y. T. Lee
Christopher J. Ryerson
Christine F. McDonald
Nicole S. L. Goh
A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease
description Abstract Dyspnoea is a cardinal symptom of fibrotic interstitial lung disease (ILD), with a lack of proven effective therapies. With emerging evidence of the role of facial and nasal airflow for relieving breathlessness, this pilot study was conducted to examine the feasibility of conducting a clinical trial of a handheld fan (HHF) for dyspnoea management in patients with fibrotic ILD. In this mixed-methods, randomised, assessor-blinded, controlled trial, 30 participants with fibrotic ILD who were dyspnoeic with a modified Medical Research Council Dyspnoea grade ≥ 2 were randomised to a HHF for symptom control or no intervention for 2 weeks. Primary outcomes were trial feasibility, change in Dyspnoea-12 scores at Week 2, and participants’ perspectives on using a HHF for dyspnoea management. Study recruitment was completed within nine months at a single site. Successful assessor blinding was achieved in the fan group [Bang’s Blinding Index − 0.08 (95% CI − 0.45, 0.30)] but not the control group [0.47 (0.12, 0.81)]. There were no significant between-group differences for the change in Dyspnoea-12 or secondary efficacy outcomes. During qualitative interviews, participants reported that using the HHF relieved breathlessness and provided relaxation, despite initial scepticism about its therapeutic benefit. Oxygen-experienced participants described the HHF being easier to use, but not as effective for symptomatic relief, compared to oxygen therapy. Our results confirmed the feasibility of a clinical trial of a HHF in fibrotic ILD. There was a high level of patient acceptance of a HHF for managing dyspnoea, with patients reporting both symptomatic benefits and ease of use.
format article
author Yet H. Khor
Kirushallini Saravanan
Anne E. Holland
Joanna Y. T. Lee
Christopher J. Ryerson
Christine F. McDonald
Nicole S. L. Goh
author_facet Yet H. Khor
Kirushallini Saravanan
Anne E. Holland
Joanna Y. T. Lee
Christopher J. Ryerson
Christine F. McDonald
Nicole S. L. Goh
author_sort Yet H. Khor
title A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease
title_short A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease
title_full A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease
title_fullStr A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease
title_full_unstemmed A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease
title_sort mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/cb52a0d140ab45edb402fb7a2ff021ce
work_keys_str_mv AT yethkhor amixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT kirushallinisaravanan amixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT anneeholland amixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT joannaytlee amixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT christopherjryerson amixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT christinefmcdonald amixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT nicoleslgoh amixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT yethkhor mixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT kirushallinisaravanan mixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT anneeholland mixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT joannaytlee mixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT christopherjryerson mixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT christinefmcdonald mixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
AT nicoleslgoh mixedmethodspilotstudyofhandheldfanforbreathlessnessininterstitiallungdisease
_version_ 1718383658558029824